Literature DB >> 11767013

Neutralizing and complement-fixing monoclonal antibodies as an aid to the diagnosis of equine herpesvirus-1 infection.

B K Singh1, M P Yadav, S C Tewari.   

Abstract

One complement-fixing (C-MAb) and three complement-dependent neutralizing monoclonal antibodies (N-MAbs) were raised against Hisar-90-7 equine herpesvirus-1 (EHV-1) strain. The target antigen of the C-MAb (2A5) and two of the N-MAbs (1H6, 9C4) was identified as a 140 kDa polypeptide in Western blotting. The target antigen of N-MAb (9C6) could not be identified. Purified polypeptides of five EHV-1 strains isolated from different regions and at different times gave intense bands at 140 kDa when reacted with N-MAb (1H6) in Western blots. In sandwich ELISA, all four MAbs captured the viral antigen from clinical materials, giving a reliable and rapid diagnosis of EHV-1 infection in equines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11767013     DOI: 10.1023/a:1012747331088

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  14 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Continuous and discontinuous protein antigenic determinants.

Authors:  D J Barlow; M S Edwards; J M Thornton
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Neutralizing determinants defined by monoclonal antibodies on polypeptides specified by bovine herpesvirus 1.

Authors:  J K Collins; A C Butcher; C A Riegel; V McGrane; C D Blair; Y A Teramoto; S Winston
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

5.  Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.

Authors:  J J Schlesinger; M W Brandriss; T P Monath
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

6.  Serological detection of equid herpesvirus 1 infections of the respiratory tract.

Authors:  G R Thomson; J A Mumford; J Campbell; L Griffiths; P Clapham
Journal:  Equine Vet J       Date:  1976-04       Impact factor: 2.888

7.  Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1.

Authors:  G P Allen; M R Yeargan
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

8.  The immunodominant glycoprotein complex of equid herpesvirus 1 (EHV-1) and the counterpart of EHV-4.

Authors:  K Okazaki; T Kumagai; E Honda; K Okazaki
Journal:  Nihon Juigaku Zasshi       Date:  1990-10

9.  Monoclonal antibodies with neutralizing activity to equine herpesvirus 1.

Authors:  M Shimizu; K Satou; N Nishioka
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Rapid detection of equine herpesvirus type-1 antigens in nasal swab specimens using an antigen capture enzyme-linked immunosorbent assay.

Authors:  R Sinclair; J A Mumford
Journal:  J Virol Methods       Date:  1992-09       Impact factor: 2.014

View more
  1 in total

1.  Development of a neutralizing monoclonal antibody-based blocking ELISA for detection of equine herpesvirus 1 antibodies.

Authors:  B K Singh; S Ahuja; B R Gulati
Journal:  Vet Res Commun       Date:  2004-07       Impact factor: 2.459

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.